Navigation Links
Scientists Spot Eye Development 'Switch'
Date:10/24/2007

Breakthrough might lead to lab-grown eyes, they say

WEDNESDAY, Oct. 24 (HealthDay News) -- British scientists say they've found a cellular signal that switches on eye development.

They said the discovery will prove valuable to scientists examining stem cells connected to eye formation.

The findings of the study, published in the Oct. 25 issue of the journal Nature, could be the start of a new line of research that eventually enables researchers to create eyes in laboratory dishes.

In experiments with frogs, the University of Warwick team found that a short burst of an energy and signaling molecule called adenosine triphosphate (ATP), followed by accumulation of another molecule called adenosine diphosphate (ADP), is an important signal for initiating expression of Eye Field Transcription Factors, genes that initiate and direct eye development.

While this finding was made in frogs, this mechanism for triggering eye development likely applies across a wide range of species, the researchers said.

More information

Here's more about eye development in vertebrates.



-- Robert Preidt



SOURCE: University of Warwick, news release, Oct. 24, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Nobel Prize for Medicine shared by Three scientists
2. Scientists plan human cloning clinic in the United States
3. Scientists crack mechanism of Leptin-Obesity Hormone
4. Scientists use plant hormones to fight cancer
5. American scientists alter gene makeup of babies
6. Expose on eating disorders!! Scientists trace “brain’s eating control center pathway”
7. Scientists found ancient Human Germ Killer
8. Scientists locate key hormone involved in appetite control
9. Scientists open the book of life
10. Electronic nose by Italian scientists
11. Scientists review SARS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)... finds more than 350 common sets of genes in patie...thDay News) -- Genetic activity in breast cancer c...s tend to more aggressive when they strike at a yo...younger women do worse than older women," said sen...of the clinical trials program in breast cancer at...
(Date:7/9/2008)...rtnership Integrates In-Store and Online Marketing...r Experience, PITTSBURGH and NEW YORK, July 9 /PR...on, ("GNC"), the largest global specialty retailer... ), the leading source of,health information, toda...increase consumer awareness and understanding of t...
(Date:7/9/2008)...ETHESDA, Md., July 9 /PRNewswire/ -- leViv, Inc. ...exclusively on nutrition and lifestyle programs fo...programs today. The new,programs include 28-days o...per day -- over 110 items in every order), online ...ucational resources, professional advice,news, he...
(Date:7/9/2008)...astfeeding.com adds to its unparalleled content on... Center,: 1400 professional articles on child, hea...s and sleep walking., BOULDER, Colo., July 9 /PRN...source with ,Everything for the New Mom, improves ...with over 1400 doctor-reviewed,professional articl...
Breaking Medicine News(10 mins):Health News:Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 2Health News:Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 3Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 3Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 2Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 3Health News:Breastfeeding.com Becomes a Premier Resource on Child Health 2
...e have discovered a tiny bacterium that could one ...phenyls (PCBs) from our environment//. The organis... detoxify commercial PCB compounds on site — witho... will appear in the April 15 issue of Applied and ...
...day has indicated the need for a cardiac departmen...cunae// in the care meted out to patients who have...kay Base Hospital. Mackay Base Hospital was found ...in 22 of the 26 categories but portrayed some worr...
...Hospital have discovered previously unsuspected mu...ric acute lymphoblastic leukemia (ALL), // the mos...y suggests novel methods for treating pediatric AL...ion of unsuspected mutations in adult cancers. &...
...im facts to state. The study estimates that more t...tism// and that it also takes more than two years ...n addition, around 125,000 Australians suffer from...d communication problems, social interaction and s...
Other Medicine News:Health News:Bacterium Could Treat PCBs Without the Need for Dredging 2Health News:Major Gene Study Uncovers Secrets of Leukemia 2Health News:Major Gene Study Uncovers Secrets of Leukemia 3
(Date:7/7/2008)...s scientific evidence supporting accuracy of, it...ajor international co...ly 7 /- Molecular,Biometrics, LLC, a ...el,clinical tools for applications in personalized... function in health and disease, presented data fr...
(Date:7/7/2008)...- Biopure Corporation,(Nasd...sions with the Food,and Drug Administration (FDA) ...r a new clinical trial of Hemopure(R) [hemoglobin ... proposed to study use of Hemopure,in patients suf...efuse,transfusion with blood components. Currently...
(Date:7/6/2008)...f Assay Submitted for FDA Clearance, SAN DIEGO, J...segment,of BD (Becton, Dickinson and Company) (NYS...D GeneOhm(TM) Cdiff molecular assay for the rapid ...nfection (CDI). It is the first CDI,diagnostic tes... one test,procedure. BD has also submitted this as...
(Date:7/3/2008)...Newswire-USNewswire/ -- All newborn infants,should...resent at birth,according to a new recommendation... recommendation and the accompanying summary of ev... Children whose hearing is impaired at birth, duri... with verbal and nonverbal communication and,socia...
Breaking Medicine Technology:Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 2Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 3Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 4Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 3Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 1Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 2Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 3Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 4Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 5Ovarian cancer risk not affected by alcohol and smoking but reduced by caffeine 9872 1Ovarian cancer risk not affected by alcohol and smoking but reduced by caffeine 9872 2Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 1Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 2Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 3Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 4Deli Chef Tri Bean Salad Recalled From Some Kroger Stores 9868 1
...Point Therapeutics, Inc.,(NASDAQ: POTP) today repo... at the 2007 Annual Meeting of the American,Associ...os Angeles,California, April 14-18, 2007. The AAC...es on talabostat,s novel mechanism of action., Add...follows: , Presentation Date and Time: Monday, Apr...
... - Ascenta Therapeutics,Inc. announced today that...ing compounds will be featured in three oral,prese...week,s 2007,Annual Meeting of the American Associa... Angeles, California April 14-18, 2007., Ascenta,s...t the,"High Impact Late-Breaking Research 1" sessi...
Other Medicine Technology:Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 2Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 3Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 4Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 5Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 6
...0 provides a new screening, diagnostic, treatment ...the medical management of sleep-related breathing ...l the unmet need for an ambulatory, reliable, pati...cessible to the great number of OSA sufferers, and...
...ulin is the C-terminal cleavage product produced d...mature insulin molecule. Although the C-peptide of... significant liver or extra-renal metabolism and t...han insulin [1]. In addition, C-peptide assays may...
...7-Hydroxy-4-androstene-3-one), a C19 steroid, is o... [1]. In postpubertal males, testosterone is secre...nt derived from peripheral conversion of androsten...that over 50% of serum testosterone is derived fro...
...s the primary active hormone synthesized within th... synthesized via a series of steps involving: (i) ...nation of tyrosine residues in the thyroglobulin s...e and 3,5-diiodotyrosine (MIT and DIT), and (iii) ...
Medicine Products: